FDA inspection
Glenmark Pharmaceuticals Limited: FDA inspection ending Feb 14, 2025
FDA inspection 1260403 · Official Action Indicated (OAI) · Dhar
Key facts
| Inspection ID | 1260403 |
|---|---|
| Firm | Glenmark Pharmaceuticals Limited |
| FEI number | 3008565058 |
| Address | Plot No 2, Pharma Zone Sez Pithampur; Phase - 2 |
| City | Dhar |
| Country | India |
| Fiscal year | 2025 |
| Inspection end date | Feb 14, 2025 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 708270 |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data